Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven

OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > History will tell you, this is the time to.....

<< Previous

Bullboard Posts

Next >>

Comment by Floridas2000on Aug 05, 2016 1:21pm

126 Views

Post# 25114611

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:History will tell you, this is the time to.....

1) If Yosprala doesn't pass then the company itself is done and Adams name will be tarnished. 2) We don't know but the competition would have to go through all the approvals so first to market would be a huge competitive advantage since approvals are tedious 3) They spent a ton of research money to define the market. In the research they outlined the doctors who would recommend this drug and the market for users to consolidate their pills. So we have to hope their research is accurate 4) Agreed

It's a speculative company, we're not talking Gilead here, so there is a large amount of risk / reward. I agreee that it could be shorted but it will take someone with big balls to short this stock ahead of a Yosprala approval. If it doubles in a few days then they're screwed. Lets see what happens, we'll know in a couple of months.

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload